Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes.

Autor: Izquierdo JL; Neumología, Hospital Universitario de Guadalajara, Guadalajara, Departamento de Medicina, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España. Electronic address: jlizquierdo@sescam.org., Miravitlles M; Departamento de Neumología, Hospital Universitari Vall d'Hebron, Barcelona, España; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España., Esquinas C; Departamento de Neumología, Hospital Universitari Vall d'Hebron, Barcelona, España., Pérez M; Departamento médico, AstraZeneca Farmacéutica, Barcelona, España., Calle M; Departamento de Neumología, Hospital Clínico San Carlos, Departamento de Medicina, Facultad de Medicina, Universidad Complutente de Madrid, Madrid, España., López Campos JL; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España; Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/Universidad de Sevilla, Sevilla, España., Rodríguez González-Moro JM; Servicio de Neumología, Hospital Universitario Principe de Asturias, Alcalá de Henares, Madrid, España., Casanova C; Hospital Universitario Nuestra Señora de Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, España., Esteban C; Servicio de Neumologia, Hospital Galdakao-Usansolo, Galdakao, Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), España., de Lucas P; Hospital General Universitario Gregorio Marañón, Madrid, España.
Jazyk: English; Spanish; Castilian
Zdroj: Archivos de bronconeumologia [Arch Bronconeumol (Engl Ed)] 2018 Nov; Vol. 54 (11), pp. 559-567. Date of Electronic Publication: 2018 May 28.
DOI: 10.1016/j.arbres.2018.03.021
Abstrakt: Introduction: The objective of this study was to analyze the clinical characteristics of COPD patients attending general respiratory clinics, adherence to clinical guidelines, classification accuracy, and therapeutic management.
Method: Multicenter, cross-sectional study, with the primary objective of describing the number, intensity, and variability of symptoms in COPD patients. Data were collected in 2015 by 300 pulmonologists who evaluated a total of 3,010 patients, of which 2,669 (88.6%) were eligible for analysis.
Results: A total of 22% were active smokers, notably 21% and 17% of GOLD groups C and D, and 17% and 19% of exacerbators in the GesEPOC classification; 62.3% had associated comorbidities. The diagnostic process was characterized by limited use of tests such as diffusion capacity or lung volumes, even in the more severe GOLD groups or the GesEPOC exacerbator phenotypes. The use of multidimensional scales, such as BODE (12%), and specific rehabilitation protocols was also rare. Treatment was based on different combinations of bronchodilators and inhaled corticosteroids. Methylxanthines were used in very few patients (7%).
Conclusions: A large proportion of COPD patients seen in respiratory clinics have non-complex disease and pulmonology tests are rarely performed. Our study confirms a slight change in treatments and the frequent association with comorbidities that can modify the clinical presentation of the patient.
(Copyright © 2018 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE